Medplus Health Services Ltd. (MEDPLUS) fundamentals
Medplus Health Services Ltd. is a listed company in Retailing, part of the Consumer Services sector, listed on the NSE as MEDPLUS (ISIN INE804L01022). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Medplus Health Services Ltd. does
MedPlus Health Services Limited is an India-based company. The Company is primarily engaged in retail trading of medicines and general items, wholesale cash and carry and pathological laboratory testing services, wholesale trading and manufacturing of pharmaceutical products, fast-moving consumer goods and beauty products. It operates through three segments: Retail, Diagnostics, and Others. The Retail segment is engaged in trading of pharmaceuticals and general items through its retail stores and online platform. The Diagnostics segment includes diagnostic services, pathological services, and laboratory testing services. The Other segment includes insurance broking business. The Company operates approximately 4,712 stores. Its omni-channel platform enables the Company to service its customers through its stores, as well as its online channels. Its e-commerce portals include MedPlus Mart, MedPlus Lens, and MedPlus Labs.
Valuation and market data
| Last close | ₹661.70 |
|---|---|
| Market capitalisation | ₹7,928 crore |
| Enterprise value | ₹9,110 crore |
| P/E (TTM) | 36.10 |
| Price to book | 4.01 |
| Price to sales (TTM) | 0.64 |
| Book value per share | ₹164.82 |
| Dividend yield | 0.00% |
| Sector | Consumer Services |
| Industry | Retailing |
| Listed since | Thu Dec 23 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹871 crore | ₹83 crore | ₹62 crore | 5.21 |
| Mar 2025 | ₹722 crore | ₹51 crore | ₹40 crore | 3.37 |
| Mar 2024 | ₹474 crore | ₹7 crore | ₹9 crore | 0.79 |
| Mar 2023 | ₹237 crore | ₹8 crore | ₹6 crore | 0.46 |
| Mar 2022 | ₹155 crore | ₹6 crore | ₹6 crore | 0.50 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 40.2% |
|---|---|
| Foreign institutions (FII) | 14.4% |
| Mutual funds | 24.5% |
| Other domestic institutions | 5.4% |
| Retail and others | 15.5% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.